The group led by Dr. Aurora Gómez-Durán has been awarded by the Mehuer and the Tatiana Pérez de Guzmán el Bueno Foundations for the development of their research

The MitoPhenomics group led by Dr. Aurora Gómez-Durán researcher at the Margarita Salas Center for Biological Research (CSIC) has been awarded at the end of December in two calls launched by the Mehuer and Tatiana Pérez Guzmán el Bueno Foundations, to develop research in the field of orphan drugs and rare neuromuscular disorders.

The call of the Mehuer Foundation, associated with the Royal and Illustrious Official College of Pharmacists of Seville, has awarded a grant endowed with € 25,000 to the project "Study of new mechanisms and treatments in mitochondrial disease" in an extraordinary call launched in August 2021. This grant recognizes the work of Dra. Goméz-Durán on mitochondrial diseases funded by the Spanish State Research Agency (AEI) and the Attracting Talent (AT) project from the Autonomous Community of Madrid (CAM). The award-winning research aims to unravel the mechanisms by which the cell recognizes mitochondrial dysfunction through activation of stress mechanisms, and in turn, whether these processes regulate the heteroplasmic load (content of mutated versus wild-type mitochondrial DNA ) in disease-causing variants (project AEI) in different human mitochondrial populations (AT-CAM).

On the other hand, the Tatiana Pérez Guzmán el Bueno Foundation has awarded Carmen Linares, a predoctoral researcher in the group of Dr. Goméz-Durán, with a grant of approximately € 100,000 within its Call for Predoctoral Scholarships in Neuroscience 2021, to work in the above-mentioned project supported by the AEI.